These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28675524)

  • 1. Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome.
    Mujagic Z; Jonkers DMAE; Ludidi S; Keszthelyi D; Hesselink MA; Weerts ZZRM; Kievit RN; Althof JF; Leue C; Kruimel JW; van Schooten FJ; Masclee AAM
    Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28675524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers for visceral hypersensitivity in patients with irritable bowel syndrome.
    Ludidi S; Mujagic Z; Jonkers D; Keszthelyi D; Hesselink M; Kruimel J; Conchillo J; Masclee A
    Neurogastroenterol Motil; 2014 Aug; 26(8):1104-11. PubMed ID: 24920528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study.
    Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Dekker J; Buurman WA; Masclee AA
    Neurogastroenterol Motil; 2015 Aug; 27(8):1127-37. PubMed ID: 26031193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral sensitivity remains stable over time in patients with irritable bowel syndrome, but with individual fluctuations.
    Josefsson A; Rosendahl A; Jerlstad P; Näslin G; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2019 Jul; 31(7):e13603. PubMed ID: 31012215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff.
    Ludidi S; Conchillo JM; Keszthelyi D; Van Avesaat M; Kruimel JW; Jonkers DM; Masclee AA
    Neurogastroenterol Motil; 2012 Aug; 24(8):729-33, e345-6. PubMed ID: 22591192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological factors selectively upregulate rectal pain perception in hypersensitive patients with irritable bowel syndrome.
    Grinsvall C; Törnblom H; Tack J; Van Oudenhove L; Simrén M
    Neurogastroenterol Motil; 2015 Dec; 27(12):1772-82. PubMed ID: 26467837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
    Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain functional connectivity is associated with visceral sensitivity in women with Irritable Bowel Syndrome.
    Icenhour A; Witt ST; Elsenbruch S; Lowén M; Engström M; Tillisch K; Mayer EA; Walter S
    Neuroimage Clin; 2017; 15():449-457. PubMed ID: 28649489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
    Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome.
    Li ZY; Mao YQ; Hua Q; Sun YH; Wang HY; Ye XG; Hu JX; Wang YJ; Jiang M
    World J Gastroenterol; 2024 Mar; 30(10):1431-1449. PubMed ID: 38596485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are characteristics of abdominal pain helpful to identify patients with visceral hypersensitivity in irritable bowel syndrome? Results of a prospective study.
    Melchior C; Bril L; Leroi AM; Gourcerol G; Ducrotté P
    Neurogastroenterol Motil; 2018 Jun; 30(6):e13290. PubMed ID: 29345401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rectal barostat in irritable bowel syndrome].
    Defilippi G C; Quera P R; Madrid S AM; Defilippi C C; Valenzuela E J
    Rev Med Chil; 2006 Dec; 134(12):1524-9. PubMed ID: 17277868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
    van der Veek PP; Van Rood YR; Masclee AA
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):321-8. PubMed ID: 18258487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome.
    Wilder-Smith CH; Robert-Yap J
    World J Gastroenterol; 2007 Jul; 13(27):3699-704. PubMed ID: 17659729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia.
    Moshiree B; Price DD; Robinson ME; Gaible R; Verne GN
    Clin J Pain; 2007 May; 23(4):323-30. PubMed ID: 17449993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.